Antidepressant may reduce agitation but worsen cognition in Alzheimer’s

A trial of the antidepressant citalopram has found that in people with Alzheimer’s, the drug may reduce agitation but may also carry risks of worsening cognition and heart problems. The paper is published on Wednesday 19 February in the journal JAMA.